Skip to main content
Therapeutic Advances in Neurological Disorders logoLink to Therapeutic Advances in Neurological Disorders
. 2012 May;5(3):181. doi: 10.1177/1756285612445143

Erratum

PMCID: PMC3349083

Abstract

The publisher would like to apologise for an error made in Therapeutic Advances in Neurological Disorders, Volume 5, Issue 2.


In the article: Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany, one of the author names, Friedemann Paul has been incorrectly spelt [1].

[1] Anke Stroet, Claudia Hemmelmann, Michaela Starck, Uwe Zettl, Jan Dörr, Friedemann Paul, et al., Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany: Ther Adv Neurol Disord 2012, 5(2) 75–79.


Articles from Therapeutic Advances in Neurological Disorders are provided here courtesy of SAGE Publications

RESOURCES